...
首页> 外文期刊>International Orthopaedics >Regenerative therapies increase survivorship of avascular necrosis of the?femoral head: a systematic review and meta-analysis
【24h】

Regenerative therapies increase survivorship of avascular necrosis of the?femoral head: a systematic review and meta-analysis

机译:再生疗法增加了对股骨头的缺血性坏死的生存:系统审查和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose The aim of this study was to document the available evidence on the use of regenerative techniques for the treatment of femoral head osteonecrosis (or avascular necrosis of femoral head, AVN) and to understand their benefit compared to core decompression (CD) alone in avoiding failure and the need for total hip replacement (THR). Methods The search was conducted on three medical electronic databases according to PRISMA guidelines. The studies reporting number and timing of failures were included in a meta-analysis calculating cumulative survivorship with a Kaplan-Mayer curve. Moreover, the results on failures in treatment groups reported in RCT were compared with those documented in control groups, in order to understand the benefit of biological therapies compared to CD for the treatment of AVN. Results Forty-eight studies were included in this systematic review, reporting results of different types of regenerative techniques: mesenchymal stem cell implantation in the osteonecrotic area, intra-arterial infiltration with mesenchymal stem cells, implantation of bioactive molecules, or platelet-rich plasma. Overall, reported results were good, with a cumulative survivorship of 80% after ten?year follow-up, and better results when regenerative treatments were combined to CD compared to CD alone (89.9% vs 70.6%,? p ?
机译:目的本研究的目的是记录有关使用再生技术的可用证据,用于治疗股骨头骨折(或股票头部,AVN)的股票头脑骨折(或股票头部的缺血性坏死),并与核心减压(CD)相比,他们的益处仅在避免时失败和总髋关节替换的需求(Thr)。方法根据Prisma指南,在三个医疗电子数据库上进行搜索。据报告数量和失败时序的研究包括在荟萃分析中,计算具有Kaplan-Mayer曲线的累积生存。此外,与对照组中记录的那些,将在RCT中报告的治疗组的失败结果进行比较,以了解与CD用于治疗AVN的生物疗法的益处。结果纳入48项研究,包括在该系统审查中,报告不同类型的再生技术的结果:骨质分解区域中的间充质干细胞植入,具有间充质干细胞的动脉内渗透,生物活性分子的植入或富含血小板的血浆。总体而言,报道的结果良好,10次累计生存率为80%以后的80%?当单独将再生处理与CD相比将再生治疗合并到CD时(89.9%VS 70.6%,H-0.0001) 。结论再生疗法为AVN治疗提供良好的临床结果。与单独的CD相比,CD与再生技术的组合具有随时间的生存方面的显着改善。需要进一步的研究来鉴定最佳程序和最合适的患者,以受益于AVN的再生治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号